• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTEN 突变型非小细胞肺癌需要 ATM 来抑制促凋亡信号并逃避放疗。

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy.

作者信息

Fischer Thomas, Hartmann Oliver, Reissland Michaela, Prieto-Garcia Cristian, Klann Kevin, Pahor Nikolett, Schülein-Völk Christina, Baluapuri Apoorva, Polat Bülent, Abazari Arya, Gerhard-Hartmann Elena, Kopp Hans-Georg, Essmann Frank, Rosenfeldt Mathias, Münch Christian, Flentje Michael, Diefenbacher Markus E

机构信息

Department of Radiation Oncology, University Hospital Würzburg, Würzburg, Germany.

Department of Biochemistry and Molecular Biology, Protein Stability and Cancer Group, University of Würzburg, Würzburg, Germany.

出版信息

Cell Biosci. 2022 Apr 27;12(1):50. doi: 10.1186/s13578-022-00778-7.

DOI:10.1186/s13578-022-00778-7
PMID:35477555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9044846/
Abstract

BACKGROUND

Despite advances in treatment of patients with non-small cell lung cancer, carriers of certain genetic alterations are prone to failure. One such factor frequently mutated, is the tumor suppressor PTEN. These tumors are supposed to be more resistant to radiation, chemo- and immunotherapy.

RESULTS

We demonstrate that loss of PTEN led to altered expression of transcriptional programs which directly regulate therapy resistance, resulting in establishment of radiation resistance. While PTEN-deficient tumor cells were not dependent on DNA-PK for IR resistance nor activated ATR during IR, they showed a significant dependence for the DNA damage kinase ATM. Pharmacologic inhibition of ATM, via KU-60019 and AZD1390 at non-toxic doses, restored and even synergized with IR in PTEN-deficient human and murine NSCLC cells as well in a multicellular organotypic ex vivo tumor model.

CONCLUSION

PTEN tumors are addicted to ATM to detect and repair radiation induced DNA damage. This creates an exploitable bottleneck. At least in cellulo and ex vivo we show that low concentration of ATM inhibitor is able to synergise with IR to treat PTEN-deficient tumors in genetically well-defined IR resistant lung cancer models.

摘要

背景

尽管非小细胞肺癌患者的治疗取得了进展,但某些基因改变的携带者仍易于治疗失败。其中一个经常发生突变的因素是肿瘤抑制因子PTEN。这些肿瘤被认为对放疗、化疗和免疫疗法更具抗性。

结果

我们证明,PTEN的缺失导致直接调节治疗抗性的转录程序表达改变,从而导致辐射抗性的建立。虽然PTEN缺陷的肿瘤细胞对辐射抗性不依赖于DNA-PK,在辐射期间也不激活ATR,但它们对DNA损伤激酶ATM有显著依赖性。通过无毒剂量的KU-60019和AZD1390对ATM进行药理学抑制,在PTEN缺陷的人和小鼠非小细胞肺癌细胞以及多细胞器官型体外肿瘤模型中,恢复了辐射敏感性,甚至与辐射产生协同作用。

结论

PTEN肿瘤依赖ATM来检测和修复辐射诱导的DNA损伤。这创造了一个可利用的瓶颈。至少在细胞内和体外,我们表明低浓度的ATM抑制剂能够与辐射协同作用,以治疗基因明确的辐射抗性肺癌模型中的PTEN缺陷肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/c68c6222ab99/13578_2022_778_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/b31a2dc44118/13578_2022_778_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/5661f9716b1b/13578_2022_778_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/7561c53a0d9d/13578_2022_778_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/6bdf2127c6fd/13578_2022_778_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/65744e5a26d1/13578_2022_778_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/bccfcf94c04c/13578_2022_778_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/c68c6222ab99/13578_2022_778_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/b31a2dc44118/13578_2022_778_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/5661f9716b1b/13578_2022_778_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/7561c53a0d9d/13578_2022_778_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/6bdf2127c6fd/13578_2022_778_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/65744e5a26d1/13578_2022_778_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/bccfcf94c04c/13578_2022_778_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4f/9044846/c68c6222ab99/13578_2022_778_Fig7_HTML.jpg

相似文献

1
PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy.PTEN 突变型非小细胞肺癌需要 ATM 来抑制促凋亡信号并逃避放疗。
Cell Biosci. 2022 Apr 27;12(1):50. doi: 10.1186/s13578-022-00778-7.
2
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.穿透血脑屏障的临床 ATM 抑制剂 AZD1390 增敏并改善临床前脑肿瘤模型的生存。
Sci Adv. 2018 Jun 20;4(6):eaat1719. doi: 10.1126/sciadv.aat1719. eCollection 2018 Jun.
3
Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM.针对 ATM 抑制剂靶向 PTEN 缺陷肿瘤细胞的机制原理。
Cancer Res. 2015 Jun 1;75(11):2159-65. doi: 10.1158/0008-5472.CAN-14-3502. Epub 2015 Apr 13.
4
Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.ATR的缺失选择性地使缺乏ATM的人乳腺上皮细胞对电离辐射和DNA损伤剂敏感。
Cell Cycle. 2014;13(22):3541-50. doi: 10.4161/15384101.2014.960729.
5
ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation.ATM激酶抑制作用优先使PTEN缺失的前列腺肿瘤细胞对电离辐射敏感。
Cancers (Basel). 2020 Dec 30;13(1):79. doi: 10.3390/cancers13010079.
6
ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.ATR和Chk1在DNA复制应激后抑制caspase-3依赖性凋亡反应。
PLoS Genet. 2009 Jan;5(1):e1000324. doi: 10.1371/journal.pgen.1000324. Epub 2009 Jan 2.
7
Regulation of DNA-dependent protein kinase activity by ionizing radiation-activated abl kinase is an ATM-dependent process.电离辐射激活的abl激酶对DNA依赖性蛋白激酶活性的调节是一个依赖ATM的过程。
J Biol Chem. 2000 Sep 29;275(39):30163-8. doi: 10.1074/jbc.M004302200.
8
Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest.非小细胞肺癌肿瘤起始细胞对 DNA 损伤治疗的耐药性涉及 DNA-PK/ATM 激活减少和细胞周期阻滞减弱。
Cell Death Dis. 2013 Jan 31;4(1):e478. doi: 10.1038/cddis.2012.211.
9
Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.共济失调毛细血管扩张症突变蛋白和DNA依赖性蛋白激酶协同作用导致DNA损伤后复制蛋白A2磷酸化
Cancer Res. 2001 Dec 1;61(23):8554-63.
10
ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin.ATM 抑制诱导合成致死,并增强 PTEN 缺失型乳腺癌细胞对顺铂的敏感性。
Exp Cell Res. 2018 May 1;366(1):24-33. doi: 10.1016/j.yexcr.2018.03.006. Epub 2018 Mar 6.

引用本文的文献

1
Mechanisms Underlying Radioresistance and Reversal Strategies in Non-Small Cell Lung Cancer.非小细胞肺癌放射抗性的潜在机制及逆转策略
Int J Mol Sci. 2025 Jul 8;26(14):6559. doi: 10.3390/ijms26146559.
2
HIV Integration into the PTEN Gene and Its Tumor Microenvironment Implications for Lung Cancer.HIV整合入PTEN基因及其对肺癌肿瘤微环境的影响
Curr Oncol. 2025 Jul 4;32(7):389. doi: 10.3390/curroncol32070389.
3
Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibition.代谢依赖性图谱确定过氧化物酶1是对ATM抑制产生抗性的驱动因素。

本文引用的文献

1
Implementation of CRISPR/Cas9 Genome Editing to Generate Murine Lung Cancer Models That Depict the Mutational Landscape of Human Disease.实施CRISPR/Cas9基因组编辑以生成描绘人类疾病突变图谱的小鼠肺癌模型。
Front Cell Dev Biol. 2021 Mar 2;9:641618. doi: 10.3389/fcell.2021.641618. eCollection 2021.
2
Pancancer survival analysis of cancer hallmark genes.泛癌生存分析癌症标志基因。
Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038/s41598-021-84787-5.
3
/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition.
Redox Biol. 2025 Mar;80:103503. doi: 10.1016/j.redox.2025.103503. Epub 2025 Jan 19.
4
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicity.致癌轴YAP/MYC/EZH2损害PTEN的肿瘤抑制活性,增强肺肿瘤发生能力。
Cell Death Discov. 2024 Oct 25;10(1):452. doi: 10.1038/s41420-024-02216-8.
5
Decoding PTEN: from biological functions to signaling pathways in tumors.解析 PTEN:从肿瘤的生物学功能到信号通路。
Mol Biol Rep. 2024 Oct 24;51(1):1089. doi: 10.1007/s11033-024-10049-y.
6
A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.综述:基因突变是揭示宫颈癌耐药性的关键。
Cancer Control. 2024 Jan-Dec;31:10732748241261539. doi: 10.1177/10732748241261539.
7
Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model.非小细胞肺癌细胞模型中适度低分割放疗的疗效
Front Oncol. 2024 Apr 24;14:1293745. doi: 10.3389/fonc.2024.1293745. eCollection 2024.
8
Double-strand DNA break repair: molecular mechanisms and therapeutic targets.双链DNA断裂修复:分子机制与治疗靶点
MedComm (2020). 2023 Oct 5;4(5):e388. doi: 10.1002/mco2.388. eCollection 2023 Oct.
9
Pten knockout affects drug resistance differently in melanoma and kidney cancer.PTEN 敲除对黑色素瘤和肾癌的耐药性有不同的影响。
Pharmacol Rep. 2023 Oct;75(5):1187-1199. doi: 10.1007/s43440-023-00523-y. Epub 2023 Sep 6.
10
Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer.PTEN在非小细胞肺癌中的治疗意义
Pharmaceutics. 2023 Aug 5;15(8):2090. doi: 10.3390/pharmaceutics15082090.
/LKB1 突变与非小细胞肺癌的 KEAP1/NRF2 依赖型放疗抵抗有关,可通过抑制谷氨酰胺酶靶向治疗。
Clin Cancer Res. 2021 Mar 15;27(6):1720-1733. doi: 10.1158/1078-0432.CCR-20-2859. Epub 2020 Dec 15.
4
Immune modulatory effects of oncogenic KRAS in cancer.致癌性 KRAS 对癌症的免疫调节作用。
Nat Commun. 2020 Oct 28;11(1):5439. doi: 10.1038/s41467-020-19288-6.
5
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.PTEN 和 DNA-PK 决定了人乳腺癌对 WEE1 抑制的敏感性和恢复能力。
Elife. 2020 Jul 6;9:e57894. doi: 10.7554/eLife.57894.
6
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.无法手术的 III 期非小细胞肺癌放化疗后失败模式和挽救性治疗分析。
Radiat Oncol. 2020 Jun 9;15(1):148. doi: 10.1186/s13014-020-01590-8.
7
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.癌症放疗增敏的 DNA 损伤反应信号通路和靶点。
Signal Transduct Target Ther. 2020 May 1;5(1):60. doi: 10.1038/s41392-020-0150-x.
8
Emerging role of PTEN loss in evasion of the immune response to tumours.PTEN 缺失在肿瘤免疫逃避中的新作用。
Br J Cancer. 2020 Jun;122(12):1732-1743. doi: 10.1038/s41416-020-0834-6. Epub 2020 Apr 24.
9
and mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort.并在观察性真实世界肺腺癌队列中作为预后生物标志物的突变。
ESMO Open. 2020 Apr;5(2). doi: 10.1136/esmoopen-2020-000706.
10
Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells.鳞状癌细胞需要通过USP28来维持∆Np63的蛋白质稳定性。
EMBO Mol Med. 2020 Apr 7;12(4):e11101. doi: 10.15252/emmm.201911101. Epub 2020 Mar 4.